Brain metastases in patients with metastatic breast cancer and BRCA1/2 mutations in cell-free DNA

被引：0
|
作者：
Neelima Vidula [1 ]
Erica Blouch [1 ]
Katherine Hesler [1 ]
Andrzej Niemierko [1 ]
Aditya Bardia [1 ]
机构：
[1] Massachusetts General Hospital Cancer Center,
[2] University of California Los Angeles,undefined
来源：
Breast Cancer Research and Treatment | 2025年 / 212卷 / 1期
关键词：
Brain metastases; Somatic BRCA mutations; Cell-free DNA; Metastatic breast cancer;
D O I：
10.1007/s10549-025-07705-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：107 / 112
页数：5
相关论文
共 50 条
  • [31] Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
    Chien, A. Jo
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 1 - 12
  • [32] Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
    A. Jo Chien
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2013, 137 : 1 - 12
  • [33] Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database
    Mailliez, Audrey
    D'Hondt, Veronique
    Lusque, Amelie
    Caron, Olivier
    Cabel, Luc
    Goncalves, Anthony
    Debled, Marc
    Gladieff, Laurence
    Ferrero, Jean-Marc
    Petit, Thierry
    Mouret-Reynier, Marie Ange
    Eymard, Jean-Christophe
    Levy, Christelle
    Uwer, Lionel
    Leheurteur, Marianne
    Desmoulins, Isabelle
    Bachelot, Thomas
    Frenel, Jean-Sebastien
    Rouge, Thibault de la Motte
    Simon, Gaetane
    Jacot, William
    Delaloge, Suzette
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (05) : 921 - 931
  • [34] Genetic Profiling of Circulating Cell-Free DNA from Cerebrospinal Fluid and Plasma in ALK-Positive Lung Cancer with Brain Metastases
    Shi, L.
    Tang, J.
    Li, M.
    Tong, L.
    Tao, H.
    Wu, W.
    Wu, H.
    Guo, L.
    Wu, W.
    Li, H.
    Meng, Q.
    Xu, L.
    Zhu, Y.
    Liu, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S697 - S698
  • [35] Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer
    Christophe Legendre
    Gerald C. Gooden
    Kyle Johnson
    Rae Anne Martinez
    Winnie S. Liang
    Bodour Salhia
    Clinical Epigenetics, 2015, 7
  • [36] The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer
    Moradi-marjaneh, Reyhaneh
    Asgharzadeh, Fereshteh
    Khordad, Elnaz
    Marjaneh, Mahdi Moradi
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (07) : 942 - 952
  • [37] Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patients
    Sultana, Gazi Nurun Nahar
    Akter, Ferdowsi
    Israfil, S. M. Hasan
    Ray, Utpal Chandra
    Jahan, Rumana Akther
    Ali, Mohammad Shawkat
    Din, Salim Al
    Rahman, Shafiqur
    Halim, Rezaul
    Alam, Mohammad Sahajadul
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
    Takeshita, Takashi
    Yamamoto, Yutaka
    Yamamoto-Ibusuki, Mutsuko
    Tomiguchi, Mai
    Sueta, Aiko
    Murakami, Keiichi
    Omoto, Yoko
    Iwase, Hirotaka
    ONCOTARGET, 2017, 8 (32) : 52142 - 52155
  • [39] Elevated level of cell-free plasma DNA is associated with breast cancer
    Zhong X.Y.
    Ladewig A.
    Schmid S.
    Wight E.
    Hahn S.
    Holzgreve W.
    Archives of Gynecology and Obstetrics, 2007, 276 (4) : 327 - 331
  • [40] Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation
    Grisolia, Piera
    Tufano, Rossella
    Iannarone, Clara
    De Falco, Antonio
    Carlino, Francesca
    Graziano, Cinzia
    Addeo, Raffaele
    Scrima, Marianna
    Caraglia, Francesco
    Ceccarelli, Anna
    Nuzzo, Pier Vitale
    Cossu, Alessia Maria
    Forte, Stefano
    Giuffrida, Raffaella
    Orditura, Michele
    Caraglia, Michele
    Ceccarelli, Michele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
12345